Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service.

MacKeigan LD, Dolovich L, Petrovic B, MacCallum L, Bojarski EA, Pojskic N.

J Am Pharm Assoc (2003). 2018 Nov - Dec;58(6):622-629. doi: 10.1016/j.japh.2018.07.003. Epub 2018 Sep 3.

PMID:
30190200
2.

Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies.

MacKeigan LD, Ijaz N, Bojarski EA, Dolovich L.

Res Social Adm Pharm. 2017 Sep - Oct;13(5):947-958. doi: 10.1016/j.sapharm.2017.03.057. Epub 2017 Mar 31.

PMID:
28462792
3.

Multiple mini-interview predictive validity for performance on a pharmacy licensing examination.

Cameron AJ, MacKeigan LD, Mitsakakis N, Pugsley JA.

Med Educ. 2017 Apr;51(4):379-389. doi: 10.1111/medu.13222. Epub 2017 Jan 24.

PMID:
28118682
4.

Development and pilot testing of a multiple mini-interview for admission to a pharmacy degree program.

Cameron AJ, Mackeigan LD.

Am J Pharm Educ. 2012 Feb 10;76(1):10. doi: 10.5688/ajpe76110.

5.

Willingness to pay for inhaled insulin: a contingent valuation approach.

Sadri H, MacKeigan LD, Leiter LA, Einarson TR.

Pharmacoeconomics. 2005;23(12):1215-27.

PMID:
16336016
6.

Instruments for measuring patient satisfaction with pharmacy services in the spanish language.

Traverso ML, MacKeigan LD.

Pharm World Sci. 2005 Aug;27(4):281-4. Review.

PMID:
16228624
7.
8.

Double discounting of QALYs.

MacKeigan LD, Gafni A, O'Brien BJ.

Health Econ. 2003 Feb;12(2):165-9.

PMID:
12563665
9.

Clinical pharmacy services in the home: Canadian case studies.

MacKeigan LD, Marshman JA, Kruk-Romanus D, Milovanovic DA, Jackevicius C, Naglie G, Einarson TR.

J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5):735-42.

PMID:
12269708
10.

Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis.

Iskedjian M, Einarson TR, MacKeigan LD, Shear N, Addis A, Mittmann N, Ilersich AL.

Clin Ther. 2002 Feb;24(2):302-16.

PMID:
11911560
11.

Patient satisfaction with pharmaceutical care: update of a validated instrument.

Larson LN, Rovers JP, MacKeigan LD.

J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):44-50.

PMID:
11833515
12.

Effects of perceived patient demand on prescribing anti-infective drugs.

Miller E, MacKeigan LD, Rosser W, Marshman J.

CMAJ. 1999 Jul 27;161(2):139-42.

13.

A short term cost-effectiveness model for oral antidiabetic medicines in Europe.

MacKeigan LD.

Pharmacoeconomics. 1998 Dec;14(6):709-10. No abstract available.

PMID:
10346421
14.

Holistic versus composite preferences for lifetime treatment sequences for type 2 diabetes.

MacKeigan LD, O'Brien BJ, Oh PI.

Med Decis Making. 1999 Apr-Jun;19(2):113-21.

PMID:
10231073
15.

Cost of providing pharmaceutical services to hospice patients.

Haugtvedt CL, MacKeigan LD, Birdwell SW, Bennett DL.

Am J Health Syst Pharm. 1995 Nov 1;52(21):2419-22.

PMID:
8564606
16.

Time preference for health gains versus health losses.

MacKeigan LD, Larson LN, Draugalis JR, Bootman JL, Burns LR.

Pharmacoeconomics. 1993 May;3(5):374-86.

PMID:
10146888
17.

Overview of health-related quality-of-life measures.

MacKeigan LD, Pathak DS.

Am J Hosp Pharm. 1992 Sep;49(9):2236-45. Review.

PMID:
1524070
18.

Concern about study design and statistical analyses in recent AJHP paper.

MacKeigan LD, McGhan WF.

Am J Hosp Pharm. 1989 Jul;46(7):1342-3. No abstract available.

PMID:
2757038
19.
20.

A review of cost-benefit and cost-effectiveness analyses of clinical pharmacy services.

MacKeigan LD, Bootman JL.

J Pharm Mark Manage. 1988 Spring;2(3):63-84. Review.

PMID:
10312728
21.

Strategies for providing pharmacy services in managed health care plans.

MacKeigan LD, Larson LN.

Am Pharm. 1988 Apr;NS28(4):49-56. No abstract available.

PMID:
3369355

Supplemental Content

Loading ...
Support Center